BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meiler C, Mühlbauer M, Johann M, Hartmann A, Schnabl B, Wodarz N, Schmitz G, Schölmerich J, Hellerbrand C. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol 2005; 11(38): 6031-6037 [PMID: 16273620 DOI: 10.3748/wjg.v11.i38.6031] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mancina RM, Ferri F, Farcomeni A, Molinaro A, Maffongelli A, Mischitelli M, Poli E, Parlati L, Burza MA, De Santis A, Attilia F, Rotondo C, Rando MM, Attilia ML, Ceccanti M, Ginanni Corradini S. A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption. Appl Clin Genet 2019;12:1-10. [PMID: 30666147 DOI: 10.2147/TACG.S187922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Medhat E, Salama H, Fouad H, Abd El Haleem H, Said M, El-Nahaas SM, Omran D. Serum Soluble CD14 in Egyptian Patients with Chronic Hepatitis C: Its Relationship to Disease Progression and Response to Treatment. J Interferon Cytokine Res 2015;35:563-8. [PMID: 25811314 DOI: 10.1089/jir.2014.0155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2006;22:263-71. [PMID: 16550041 DOI: 10.1097/01.mog.0000218963.93806.d3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
4 Askar E, Ramadori G, Mihm S. Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection. World J Gastroenterol 2009; 15(31): 3884-3890 [PMID: 19701968 DOI: 10.3748/wjg.15.3884] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Moghadampour M, Eskandari-Nasab E, Shabani F. Relationship between CD14-159C/T gene polymorphism and acute brucellosis risk. Asian Pac J Trop Med 2016;9:247-51. [PMID: 26972395 DOI: 10.1016/j.apjtm.2016.01.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
6 Fernández-Calderón D, Fernández F, Ruiz-Curado S, Verdejo-García A, Lozano ÓM. Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics. Drug Alcohol Depend 2015;149:31-9. [PMID: 25682479 DOI: 10.1016/j.drugalcdep.2015.01.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
7 Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21(41): 11552-11566 [PMID: 26556986 DOI: 10.3748/wjg.v21.i41.11552] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
8 Von Hahn T, Halangk J, Witt H, Neumann K, Müller T, Puhl G, Neuhaus P, Nickel R, Beuers U, Wiedenmann B. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease. Scand J Gastroenterol. 2008;43:584-592. [PMID: 18415752 DOI: 10.1080/00365520701806065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
9 Lødrup Carlsen KC, Granum B. Soluble CD14: role in atopic disease and recurrent infections, including otitis media. Curr Allergy Asthma Rep 2007;7:436-43. [PMID: 17986374 DOI: 10.1007/s11882-007-0067-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
10 Mertens J, Bregadze R, Mansur A, Askar E, Bickeböller H, Ramadori G, Mihm S. Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity. J Mol Med (Berl) 2009;87:815-24. [PMID: 19468702 DOI: 10.1007/s00109-009-0479-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
11 Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655-666. [PMID: 22886237 DOI: 10.1038/nrmicro2848] [Cited by in Crossref: 268] [Cited by in F6Publishing: 257] [Article Influence: 29.8] [Reference Citation Analysis]
12 Lazo M, Mitchell MC. Epidemiology and Risk Factors for Alcoholic Liver Disease. In: Chalasani N, Szabo G, editors. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing; 2016. pp. 1-20. [DOI: 10.1007/978-3-319-20538-0_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Machado M, Cortez-pinto H. Are genes really important in alcoholic liver disease?: . European Journal of Gastroenterology & Hepatology 2008;20:1244-8. [DOI: 10.1097/meg.0b013e328304b6dd] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780-790. [PMID: 21252259 DOI: 10.1093/infdis/jiq118] [Cited by in Crossref: 734] [Cited by in F6Publishing: 745] [Article Influence: 73.4] [Reference Citation Analysis]
15 Dou Y, van Montfoort N, van den Bosch A, Janssen HLA, de Man RA, Buschow SI, Woltman AM. Elevated serum levels of soluble CD14 in HBeAg-positive chronic HBV patients upon Peginterferon treatment are associated with treatment response. J Viral Hepat 2019;26:1076-85. [PMID: 31090247 DOI: 10.1111/jvh.13127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Bhonchal S, Nain CK, Prasad KK, Nada R, Sharma AK, Sinha SK, Singh K. Functional and morphological alterations in small intestine mucosa of chronic alcoholics. J Gastroenterol Hepatol 2008;23:e43-8. [PMID: 17683494 DOI: 10.1111/j.1440-1746.2007.05080.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
17 Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. 2011;141:1220-1230, 1230.e1-1230.e3. [PMID: 21726511 DOI: 10.1053/j.gastro.2011.06.063] [Cited by in Crossref: 196] [Cited by in F6Publishing: 195] [Article Influence: 19.6] [Reference Citation Analysis]
18 Cachem FCOF, Dias AS, Monteiro C, Castro JR, Fernandes G, Delphim L, Almeida AJ, Tavares F, Maciel AMA, Amendola-Pires MM, Brandão-Mello CE, Bento CAM. The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C. Immunology 2017;151:167-76. [PMID: 28140446 DOI: 10.1111/imm.12720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]